Current approaches to the management of pneumatosis intestinalis: an American Pediatric Surgical Association membership survey

Pediatr Surg Int. 2022 Dec;38(12):1965-1970. doi: 10.1007/s00383-022-05249-1. Epub 2022 Oct 15.

Abstract

Purpose: Pneumatosis intestinalis (PI) remains difficult to treat as it can lead to a broad range of clinical sequalae and there are little published data available to guide management. Our aim was to evaluate how pediatric surgeons currently manage children with PI, how treatment varies based on etiology, and to identify opportunities to optimize current PI management strategies.

Methods: We administered a web-based survey of practicing pediatric surgeons in the United States and Canada. The survey was distributed to all members of the American Pediatric Surgical Association.

Results: Of 1508 distributed surveys, 333 responses were received (22% response rate); 174 were complete and included in analysis (12% analyzed). For all scenarios, respondents recommended treatment for PI include a median 7 days of bowel rest and 7 days antibiotics. Only 41% reported their approach to PI management was optimal. Ways to optimize care include treatment based on etiology (83%), decreased number of repeat images (64%), shorter NPO course (49%), and shorter antibiotic course (47%).

Conclusion: Pediatric surgeons manage PI similarly regardless of etiology but most report this is suboptimal. Future work is needed to prospectively evaluate management protocols that consider etiology.

Keywords: APSA survey; Neutropenic enterocolitis; Pneumatosis intestinalis.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Humans
  • Intestines
  • Pneumatosis Cystoides Intestinalis* / drug therapy
  • Pneumatosis Cystoides Intestinalis* / surgery
  • Surgeons*
  • Surveys and Questionnaires
  • United States

Substances

  • Anti-Bacterial Agents